A Utah mother battling a rare terminal cancer planned her funeral after being diagnosed with three months to live.

A single Utah mother of two was told she has three months to live after she was diagnosed with terminal cancer and Cushing ...

Dr. Leal discusses how the management of extensive stage small cell lung cancer (ES-SCLC) requires careful consideration of treatment options, balancing survival benefits against potential adverse ...

Immune cells used for adoptive immune cell therapy, originate from the patients themselves (autologous) or from someone other ...

Rachel Allbaugh, DVM, MS, DACVO, explains her squamous cell carcinoma diagnosis procedure, beyond just the clinical signs ...

Dr. Leal discusses how the primary goals of therapy for patients with extensive stage small cell lung cancer (ES-SCLC) include balancing the potential survival benefits of subsequent treatment lines ...

After hours of company pushback, FDA's Oncologic Drugs Advisory Committee voted that the benefit of immunotherapy in low or ...

Recent research suggests that Gen X and millennial Americans are at higher risk of developing several different cancers than older generations, but could the key to prevention lie in our morning ...

Surgery was the most effective treatment for cutaneous squamous cell carcinoma in situ, however, variations among other treatment approaches exist.

People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both ...

Joyce实验室已证实CSF-1R抑制能将这些免疫细胞重新编程为抗肿瘤状态，从而诱导肿瘤显著消退。然而，正如Science期刊报道的那样，大约一半的小鼠在对这种疗法产生初步反应后出现复发。Joyce说，“最引人注目的是，每次脑瘤在接受免疫疗法后复发， ...

A Utah mother who has been fighting for life after being diagnosed with a rare terminal cancer has now been given three ...